Abstract
Chronic heart failure (CHF) is a complex multifactorial clinical syndrome leading to abnormal cardiac structure and function. The severe form of this ailment is characterized by high disability, high mortality, and morbidity. Worldwide, 2–17% of patients die at first admission, of which 17–45% die within 1 year of admission and >50% within 5 years. Yangshen Maidong Decoction (YSMDD) is frequently used to treat the deficiency and pain of the heart. The specific mechanism of action of YSMDD in treating CHF, however, remains unclear. Therefore, a network pharmacology-based strategy combined with molecular docking and molecular dynamics simulations was employed to investigate the potential molecular mechanism of YSMDD against CHF. The effective components and their targets of YSMDD and related targets of CHF were predicted and screened based on the public database. The network pharmacology was used to explore the potential targets and possible pathways that involved in YSMDD treated CHF. Molecular docking and molecular dynamics simulations were performed to elucidate the binding affinity between the YSMDD and CHF targets. Screen results, 10 main active ingredients, and 6 key targets were acquired through network pharmacology analysis. Pathway enrichment analysis showed that intersectional targets associated pathways were enriched in the Prostate cancer pathway, Hepatitis B pathway, and C-type lectin receptor signaling pathways. Molecular docking and molecular dynamics simulations analysis suggested 5 critical active ingredients have high binding affinity to the 5 key targets. This research shows the multiple active components and molecular mechanisms of YSMDD in the treatment of CHF and offers resources and suggestions for future studies.
Graphical Abstract
Similar content being viewed by others
References
Chen, L., Wei, N. & Jiang, Y. et al. (2023). Comparative pharmacokinetics of seven bioactive components after oral administration of crude and processed Qixue Shuangbu Prescription in chronic heart failure rats by microdialysis combined with UPLC-MS/MS. Journal of Ethnopharmacology, 303, 116035.
Zhang, H., Zhang, L. & Yin, K. et al. (2023). Analysis of function role and long noncoding RNA expression in chronic heart failure rats treated with Hui Yang Jiu Ji decoction. Journal of Healthcare Engineering, 2023, 7438567.
Gheorghiade, M., Abraham, W. T., & Albert, N. M., et al. (2006). Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA, 296(18), 2217–2226.
West, R., Liang, L. & Fonarow, G. C. et al. (2011). Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry. European Journal of Heart Failure, 13(9), 945–952.
Towbin, J. A. (2014). Inherited cardiomyopathies. Circulation Journal, 78(10), 2347–2356.
Epelman, S., Liu, P. P. & Mann, D. L. (2015). Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nature Reviews Immunology, 15(2), 117–129.
Heidenreich, P. A., Bozkurt, B., & Aguilar, D., et al. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145(18), e895–e1032.
Mascolo, A., di Mauro, G. & Cappetta, D. et al. (2022). Current and future therapeutic perspective in chronic heart failure. Pharmacological Research, 175, 106035
McDonagh, T. A., Metra, M. & Adamo, M. et al. (2023). 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 44(37), 3627–3639.
Yuan, C., Wu, Z., & Jin, C., et al. (2023). Qiangxin recipe improves doxorubicin-induced chronic heart failure by enhancing KLF5-mediated glucose metabolism. Phytomedicine, 112, 154697.
Wang, Y., Wang, Q. & Li, C. et al. (2017). A review of chinese herbal medicine for the treatment of chronic heart failure. Current Pharmaceutical Design, 23(34), 5115–5124.
Wang, Z., Jiang, R. & Wang, L. et al. (2020). Ginsenoside Rg1 improves differentiation by inhibiting senescence of human bone marrow mesenchymal stem cell via GSK-3β and β-catenin. Stem Cells International, 2020, 2365814.
Zhang, S., Wu, H. & Liu, J. et al. (2018). Medication regularity of pulmonary fibrosis treatment by contemporary traditional Chinese medicine experts based on data mining. Journal of Thoracic Disease, 10(3), 1775–1787.
Cao, H., Li, C. & Lei, L. et al. (2020). Stachyose improves the effects of berberine on glucose metabolism by regulating intestinal microbiota and short-chain fatty acids in spontaneous type 2 diabetic KKAy mice. Frontiers in Pharmacology, 11, 578943.
Bulpitt, C. J., Li, Y. & Bulpitt, P. F. et al. (2007). The use of orchids in Chinese medicine. Journal of the Royal Society of Medicine, 100(12), 558–563.
Zhao, Z. X., Fu, J. & Ma, S. R., et al. (2018). Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin. Theranostics, 8(21), 5945–5959.
Zhang, Y., Li, W. & Chen, T. T. et al. (2020). Chemical fingerprint analysis and ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry-based metabolomics study of the protective effect of buxue yimu granule in medical-induced incomplete abortion rats. Frontiers in Pharmacology, 11, 578217.
Wu, Y., Xu, S. & Tian, X. Y. (2020). The effect of salvianolic acid on vascular protection and possible mechanisms. Oxidative Medicine and Cellular Longevity, 2020, 5472096.
Fan, Q., Liu, Y. & Rao, J. et al. (2020). Anti-atherosclerosis effect of angong Niuhuang Pill via regulating Th17/Treg immune balance and inhibiting chronic inflammatory on ApoE-/- mice model of early and mid-term atherosclerosis. Frontiers in Pharmacology, 10, 1584.
Li, Q., Bai, C. & Yang, R. et al. (2020). Deciphering the pharmacological mechanisms of Ma Xing Shi Gan decoction against COVID-19 through integrating network pharmacology and experimental exploration. Frontiers in Pharmacology, 11, 581691.
Zhang, R., Zhu, X. & Bai, H. et al. (2019). Network pharmacology databases for traditional Chinese Medicine: Review and assessment. Frontiers in Pharmacology, 10, 123.
Wang, X., Wang, Z. Y. & Zheng, J. H. et al. (2021). TCM network pharmacology: A new trend towards combining comutational, experimental and clinical approaches. Chinese Journal of Natural Medicines, 19, 1–11.
Sharma, J., Bhardwaj, V. K. & Das, P. et al. (2021). Identification of naturally originated molecules as γ-aminobutyric acid receptor antagonist. Journal of Biomolecular Structure and Dynamics, 39(3), 911–922.
Kumar, A., Rajendran, V. & Sethumadhavan, R., et al. (2013). Molecular dynamic simulation reveals damaging impact of RAC1 F28L mutation in the switch I region. PLoS One, 8(10), e77453.
Kumar, A., Rajendran, V. & Sethumadhavan, R. et al. (2013). Evidence of colorectal cancer-associated mutation in MCAK: a computational report. Cell Biochemistry and Biophysics, 67(3), 837–851.
Singh, R., Bhardwaj, V. K. & Sharma, J. et al. (2022). Identification of selective cyclin-dependent kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico exploration. Journal of Biomolecular Structure and Dynamics, 40(17), 7693–7701.
Kumar, A., Rajendran, V. & Sethumadhavan, R. et al. (2014). Computational SNP analysis: current approaches and future prospects. Cell Biochemistry and Biophysics, 68(2), 233–239.
Kumar, S., Sinha, K. & Sharma, R. et al. (2019). Phloretin and phloridzin improve insulin sensitivity and enhance glucose uptake by subverting PPARγ/Cdk5 interaction in differentiated adipocytes. Experimental Cell Research, 383(1), 111480.
Ru, J., Li, P. & Wang, J. et al. (2014). TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6, 13.
Fang, S., Dong, L. & Liu, L. et al. (2021). HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Research, 49, D1197–D1206.
Wang, J. & Hou, T. (2015). Advances in computationally modeling human oral bioavailability. Advanced Drug Delivery Reviews, 86, 11–16.
Zhang, J., Zhou, Y. & Ma, Z. (2021). Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking. Annals of Medicine, 53, 1090–1098.
Xu, X., Zhang, W. & Huang, C. et al. (2012). A novel chemometric method for the prediction of human oral bioavailability. International Journal of Molecular Sciences, 13, 6964–6982.
Daina, A., Michielin, O. & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717.
Daina, A., Michielin, O. & Zoete, V. (2019). SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research, 47, W357–W364.
Guo, X., Ji, J., & Jose Kumar Sreena, G. S., et al. (2020). Computational Prediction of Antiangiogenesis Synergistic Mechanisms of Total Saponins of Panax japonicus Against Rheumatoid Arthritis. Front Pharmacol, 11, 566129.
UniProt Consortium. (2023). UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Research, 51, D523–D531..
Shannon, P., Markiel, A. & Ozier, O. et al. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research, 13, 2498–2504.
Barrett, T., Wilhite, S. E. & Ledoux, P. et al. (2013). NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Research, 41, D991–D995.
Smih, F., Desmoulin, F., & Berry, M., et al. (2011). Blood signature of pre-heart failure: a microarrays study. PLoS One, 6, e20414.
Zhou, G., Soufan, O. & Ewald, J. et al. (2019). NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Research, 47, W234–W241.
Szklarczyk, D., Kirsch, R. & Koutrouli, M. et al. (2023). The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Research, 51, D638–D646.
Yu, G., Wang, L. G., & Han, Y., et al. (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS, 16, 284–287.
Walter, W., Sánchez-Cabo, F., & Ricote, M. (2015). GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics, 31, 2912–2914.
O’Boyle, N. M., Banck, M. & James, C. A. et al. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3, 33.
Wang, Y. H., Zhou, M. Z. & Ye, T. et al. (2022). Discovery of a Series of 5-Amide-1H-pyrazole-3-carboxyl Derivatives as Potent P2Y(14)R antagonists with anti-inflammatory characters. Journal of Medicinal Chemistry, 65, 15967–15990.
Li, X., Wei, S. & Niu, S. et al. (2022). Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis. Computers in Biology and Medicine, 144, 105389.
Tang, S., Liu, Y. & Liu, B. (2022). Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension. Scientific Reports, 12, 10154.
Shang, L., Wang, Y. & Li, J. et al. (2023). Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation. Journal of Ethnopharmacology, 302(Pt A), 115876.
Du, L., Du, D. H. & Chen, B. et al. (2020). Anti-inflammatory activity of sanjie zhentong capsule assessed by network pharmacology analysis of adenomyosis treatment. Drug Design, Development and Therapy, 14, 697–713.
Liu, J., Yang, Y., & Zeng, Y., et al. (2023). Exploring the mechanism of physcion-1-O-β-D-monoglucoside against acute lymphoblastic leukaemia based on network pharmacology and experimental validation. Heliyon, 9(3), e14009.
Dutkiewicz, Z. & Mikstacka, R. (2018). Structure-based drug design for cytochrome P450 family 1 inhibitors. Bioinorganic Chemistry and Applications, 2018, 3924608.
Vora, J., Athar, M. & Sinha, S. et al. (2020). Binding insight of Anti-HIV phytocompounds with prime targets of HIV: A molecular dynamics simulation analysis. Current HIV Research, 18, 132–141.
Liu, J., Rong, Q., & Zhang, C., et al. (2023). The mechanism of mori folium and eucommiae cortex against cyclophosphamide-induced immunosuppression integrating network pharmacology, molecular docking, molecular dynamics simulations, and experimental validation. Metabolites, 13, 1151.
Gąsiorowski, A. & Dutkiewicz, J. (2013). Comprehensive rehabilitation in chronic heart failure. Annals of Agricultural and Environmental Medicine, 20, 606–612.
Chang, X., Zhang, T. & Wang, J. et al. (2021). SIRT5-related desuccinylation modification contributes to quercetin-induced protection against heart failure and high-glucose-prompted cardiomyocytes injured through regulation of mitochondrial quality surveillance. Oxidative Medicine and Cellular Longevity, 2021, 5876841.
Wang, S. H., Tsai, K. L. & Chou, W. C. et al. (2022). Quercetin mitigates cisplatin-induced oxidative damage and apoptosis in cardiomyocytes through Nrf2/HO-1 signaling pathway. The American Journal of Chinese Medicine, 50, 1281–1298.
Maksymchuk, O., Shysh, A. & Kotliarova, A. (2023). Quercetin inhibits the expression of MYC and CYP2E1 and reduces oxidative stress in the myocardium of spontaneously hypertensive rats. Acta Biochimica Polonica, 70, 199–204.
Erlund, I., Kosonen, T. & Alfthan, G. et al. (2000). Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. European Journal of Clinical Pharmacology, 56(8), 545–553.
Zhang, L., Guo, Z. & Wang, Y. et al. (2019). The protective effect of kaempferol on heart via the regulation of Nrf2, NF-kappabeta, and PI3K/Akt/GSK-3beta signaling pathways in isoproterenol-induced heart failure in diabetic rats. Drug Development Research, 80, 294–309.
Du, Y., Han, J. & Zhang, H. et al. (2019). Kaempferol prevents against Ang II-induced cardiac remodeling through attenuating Ang II-induced inflammation and oxidative stress. Journal of Cardiovascular Pharmacology, 74, 326–335.
Zabela, V., Sampath, C., & Oufir, M., et al. (2016). Pharmacokinetics of dietary kaempferol and its metabolite 4-hydroxyphenylacetic acid in rats. Fitoterapia, 115, 189–197.
Wong, H. S., Chen, N. & Leong, P. K. et al. (2014). beta-Sitosterol enhances cellular glutathione redox cycling by reactive oxygen species generated from mitochondrial respiration: protection against oxidant injury in H9c2 cells and rat hearts. Phytotherapy Research, 28, 999–1006.
Koc, K., Geyikoglu, F. & Cakmak, O. et al. (2021). The targets of beta-sitosterol as a novel therapeutic against cardio-renal complications in acute renal ischemia/reperfusion damage. Naunyn-Schmiedeberg's Archives of Pharmacology, 394, 469–479.
Salen, G., Ahrens, E. H. & Grundy, S. M. (1970). Metabolism of beta-sitosterol in man. Journal of Clinical Investigation, 49(5), 952–967.
He, F., Xu, B. L. & Chen, C. et al. (2016). Methylophiopogonanone A suppresses ischemia/reperfusion-induced myocardial apoptosis in mice via activating PI3K/Akt/eNOS signaling pathway. Acta Pharmacologica Sinica, 37, 763–771.
Wu, X., Sun, S. & Wu, X. et al. (2022). Identification of the metabolites of methylophiopogonanone A by ultra-high-performance liquid chromatography combined with high-resolution mass spectrometry. Rapid Communications in Mass Spectrometry, 36(12), e9304.
Radosinska, J., Barancik, M. & Vrbjar, N. (2017). Heart failure and role of circulating MMP-2 and MMP-9. Panminerva Medica, 59, 241–253.
Yabluchanskiy, A., Ma, Y., & Iyer, R. P., et al. (2013). Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology (Bethesda), 28, 391–403.
Nandi, S. S., Katsurada, K. & Sharma, N. M. et al. (2020). MMP9 inhibition increases autophagic flux in chronic heart failure. The American Journal of Physiology-Heart and Circulatory Physiology, 319, 1414–1437.
Dai, B., Cui, M. & Zhu, M. et al. (2013). STAT1/3 and ERK1/2 synergistically regulate cardiac fibrosis induced by high glucose. Cellular Physiology and Biochemistry, 32, 960–971.
Sandek, A., Gertler, C. & Valentova, M. et al. (2024). Increased expression of proinflammatory genes in peripheral blood cells is associated with cardiac cachexia in patients with heart failure with reduced ejection fraction. Journal of Clinical Medicine, 13(3), 733.
Wu, L., Archacki, S. R. & Zhang, T. et al. (2007). Induction of high STAT1 expression in transgenic mice with LQTS and heart failure. Biochemical and Biophysical Research Communications, 358, 449–454.
Scarabelli, T. M., Mariotto, S. & Abdel-Azeim, S. et al. (2009). Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia/reperfusion-induced injury. FEBS Letters, 583, 531–541.
Cui, J., Zhu, L., & Xia, X., et al. (2010). NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell, 141, 483–496.
Tsuchiya Y., Asano T., Nakayama K., et al. Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation. Molecular Cell 39, 570-582.
Patel, V., Carrion, K. & Hollands, A. et al. (2015). The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-kappaB signaling, and inflammatory gene expression in human aortic valve cells. The FASEB Journal, 29, 1859–1868.
Wakatsuki, S., Suzuki, J. & Ogawa, M. et al. (2008). A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration. Expert Opinion on Therapeutic Targets, 12(12), 1469–1476.
Dong, P. L., Li, H. & Yu, X. J. et al. (2022). Effect and mechanism of “Danggui-kushen” herb pair on ischemic heart disease. Biomedicine & Pharmacotherapy, 145, 112450.
Shi, Y., An, J. & Liang, J. et al. (1999). Characterization of a mutant pancreatic eIF-2alpha kinase, PEK, and co-localization with somatostatin in islet delta cells. Journal of Biological Chemistry, 274, 5723–5730.
You, K., Wang, L. & Chou, C. H., et al. (2021). QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis. Science, 371, 6524.
Arrieta, A., Blackwood, E. A. & Glembotski, C. C. (2018). ER protein quality control and the unfolded protein response in the heart. Current Topics in Microbiology and Immunology, 414, 193–213.
Gao, G., Xie, A. & Zhang, J. et al. (2013). Unfolded protein response regulates cardiac sodium current in systolic human heart failure. Circulation: Arrhythmia and Electrophysiology, 6, 1018–1024.
Petri, E. T., Errico, A., & Escobedo, L., et al. (2007). The crystal structure of human cyclin B. Cell Cycle, 6, 1342–1349.
Bao, L., Odell, A. F., & Stephen, S. L., et al. (2012). The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence. FEBS Journal, 279, 4576–4588.
Yang, D., Fu, W. & Li, L. et al. (2017). Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction. Clinical Science, 131, 2919–2932.
Abouleisa, R. R. E., Salama, A. B. M., & Ou, Q., et al. (2022). Transient cell cycle induction in cardiomyocytes to treat subacute ischemic heart failure. Circulation, 145(17), 1339–1355.
Jakob, S., Schroeder, P. & Lukosz, M. et al. (2008). Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase. Journal of Biological Chemistry, 283, 33155–33161.
Lee, H. H. & Chang, Z. F. (2008). Regulation of RhoA-dependent ROCKII activation by Shp2. Journal of Cell Biology, 181, 999–1012.
Noda, S., Takahashi, A. & Hayashi, T. et al. (2016). Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling. Biochemical and Biophysical Research Communications, 469, 1133–1139.
Kontaridis, M. I., Yang, W., & Bence, K. K., et al. (2008). Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the Erk/MAPK and RhoA signaling pathways. Circulatio, 117, 1423–1435.
Daoud, E. & Zwick, D. (2019). Noonan syndrome case report: PTPN11 and other potential genetic factors contributing to lethal hypertrophic right ventricular cardiomyopathy. Pediatric and Developmental Pathology, 22, 386–390.
Tabib, A., Talebi, T. & Ghasemi, S. et al. (2022). A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects. European Journal of Medical Research, 27, 286.
Zhang, Y., Zhao, H. & Xu, W. et al. (2019). High expression of PQBP1 and low expression of PCK2 are associated with metastasis and recurrence of osteosarcoma and unfavorable survival outcomes of the patients. Journal of Cancer, 10(9), 2091–2101.
Zhao, X., Ren, Y. & Ren, H. et al. (2021). The mechanism of myocardial fibrosis is ameliorated by myocardial infarction-associated transcript through the PI3K/Akt signaling pathway to relieve heart failure. Journal of International Medical Research, 49(7), 3000605211031433.
Guo, D., Zheng, Q. H. & Wang, D. et al. (2024). Investigation on the mechanism of Qiangxinhuoli prescription in the treatment of chronic heart failure based on p38-MAPK signaling pathway. Traditional Medicine Research, 9(7), 38.
Tang, Y., Xu, Z., Chen, X. et al. (2021). Effects of enalapril on TLR2/NF-κB signaling pathway and inflammatory factors in rabbits with chronic heart failure. Evidence-Based Complementary and Alternative Medicine, 2021, 9594607.
Zhang, Y., Zhu, M. & Zhang, F. et al. (2019). Integrating pharmacokinetics study, network analysis, and experimental validation to uncover the mechanism of qiliqiangxin capsule against chronic heart failure. Frontiers in Pharmacology, 10, 1046.
Bolli, R., Dawn, B. & Xuan, Y. T. (2003). Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends in Cardiovascular Medicine, 13(2), 72–79.
Barry, S. P., Townsend, P. A. & Latchman, D. S. et al. (2007). Role of the JAK-STAT pathway in myocardial injury. Trends in Molecular Medicine, 13(2), 82–89.
Protti, A., Mongue-Din, H. & Mylonas, K. J. et al. (2016). Bone marrow transplantation modulates tissue macrophage phenotype and enhances cardiac recovery after subsequent acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 90, 120–128.
De Angelis, E., Pecoraro, M. & Rusciano, M. R. et al. (2019). Cross-talk between neurohormonal pathways and the immune system in heart failure: A review of the literature. International Journal of Molecular Sciences, 20(7), 1698.
Yi, T., Chen, Y., & Wang, L., et al. (2009). Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood, 114(14), 3101–3112.
Gröschel, C., Sasse, A. & Röhrborn, C. et al. (2017). T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure. Scientific Reports, 7(1), 15998.
Liu, L., Jiao, Y. & Yang, M. et al. (2023). Network pharmacology, molecular docking and molecular dynamics to explore the potential immunomodulatory mechanisms of deer antler. International Journal of Molecular Sciences, 24, 10370.
Tinberg, C. E., Khare, S. D., & Dou, J., et al. (2013). Computational design of ligand-binding proteins with high affinity and selectivity. Nature, 501, 212–216.
Author contributions
Wei Cheng: Writing. Bofeng Zhang: Data curation. Na Chen: Software. Qun Liu: Validation. Xin Ma: Validation. Xiao Fu: Validation. Min Xu: Supervision, Project administration, Funding acquisition. All authors reviewed the manuscript. All authors contributed to the work and approved the final manuscript.
Funding
This work was financially supported by the Inheritance Studio Construction Project of National Famous Old Traditional Chinese Medicine (Zhang Hongxing) (No. GZYYRJH [2022]75).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cheng, W., Zhang, BF., Chen, N. et al. Molecular Mechanism of Yangshen Maidong Decoction in the Treatment of Chronic Heart Failure based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations. Cell Biochem Biophys 82, 1433–1451 (2024). https://doi.org/10.1007/s12013-024-01297-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-024-01297-7